|
|
|
|
LEADER |
00000nam a22000005i 4500 |
001 |
978-1-59745-180-2 |
003 |
DE-He213 |
005 |
20220118195447.0 |
007 |
cr nn 008mamaa |
008 |
100301s2009 xxu| s |||| 0|eng d |
020 |
|
|
|a 9781597451802
|9 978-1-59745-180-2
|
024 |
7 |
|
|a 10.1007/978-1-59745-180-2
|2 doi
|
050 |
|
4 |
|a RC1-1245
|
072 |
|
7 |
|a MJC
|2 bicssc
|
072 |
|
7 |
|a MED022090
|2 bisacsh
|
072 |
|
7 |
|a MJC
|2 thema
|
082 |
0 |
4 |
|a 616
|2 23
|
245 |
1 |
0 |
|a Antimicrobial Drug Resistance
|h [electronic resource] :
|b Mechanisms of Drug Resistance, Volume 1 /
|c edited by Douglas Mayers.
|
250 |
|
|
|a 1st ed. 2009.
|
264 |
|
1 |
|a Totowa, NJ :
|b Humana Press :
|b Imprint: Humana,
|c 2009.
|
300 |
|
|
|a XXVI, 678 p.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
490 |
1 |
|
|a Infectious Disease
|
505 |
0 |
|
|a General Overview -- History of Drug-Resistant Microbes -- Evolutionary Biology of Drug Resistance -- Pharmacology of Drug Resistance -- Antimicrobial Resistance Versus the Discovery and Development of New Antimicrobials -- General Mechanisms of Drug Resistance -- Genetic Mechanisms of Transfer of Drug Resistance -- Mutations as a Basis of Antimicrobial Resistance -- Target-Mediated Antibacterial Resistance -- Biochemical Logic of Antibiotic Inactivation and Modification -- Antibiotic Resistance Due to Reduced Uptake -- Transport Mechanisms of Resistance to Drugs and Toxic Metals -- The Functional Resistance of Bacterial Biofilms -- Bacterial Drug Resistance - Mechanisms -- The Importance of ?-Lactamases to the Development of New ?-Lactams -- Penicillin-Binding Proteins and ?-Lactam Resistance -- Aminoglycosides: Mechanisms of Action and Resistance -- Tetracycline and Chloramphenicol Resistance Mechanisms -- Fluoroquinolone Resistance in Bacteria -- Plasmid-Mediated Quinolone Resistance -- Macrolides and Lincosamides -- Mechanism of Resistance in Metronidazole -- Glycopeptide Resistance in Enterococci -- Streptogramin -- Resistance to Linezolid -- Sulfonamides and Trimethoprim -- Mechanisms of Action and Resistance of Antimycobacterial Agents -- Fungal Drug Resistance - Mechanisms -- Amphotericin B: Polyene Resistance Mechanisms -- Fungal Drug Resistance: Azoles -- Flucytosine: Site of Action, Mechanism of Resistance and Use in Combination Therapy -- Echinocandins: Exploring Susceptibility and Resistance -- Antifungal Targets, Mechanisms of Action, and Resistance in Candida albicans -- Viral Drug Resistance - Mechanisms -- Mechanisms of Resistance of Antiviral Drugs Active Against the Human Herpes Viruses -- Influenza M2 Ion-Channel and Neuraminidase Inhibitors -- Molecular Mechanisms of Resistance to Nucleoside Reverse Transcriptase Inhibitors -- Resistance to HIV Non-Nucleoside Reverse Transcriptase Inhibitors -- Resistance to HIV-1 Protease Inhibitors -- Resistance to Enfuvirtide and Other HIV Entry Inhibitors -- Resistance to Inhibitors of Human Immunodeficiency Virus Type I Integration -- The Hepatitis B Virus and Antiviral Drug Resistance: Causes, Patterns, and Mechanisms -- Mechanisms of Hepatitis C Virus Drug Resistance -- Parasitic Drug Resistance - Mechanisms -- Drug Resistance Mechanisms in Entamoeba histolytica, Giardia lamblia, Trichomonas vaginalis, and Opportunistic Anaerobic Protozoa -- Mechanisms of Antimalarial Drug Resistance -- Drug Resistance in Leishmania -- Drug Resistance in African Trypanosomiasis -- Drug Resistance and Emerging Targets in the Opportunistic Pathogens Toxoplasma gondii and Cryptosporidium parvum -- Drug Resistance in Nematodes -- Chemotherapy and Drug Resistance in Schistosomiasis,Fascioliasis and Tapeworm Infections -- Drug Resistance in Ectoparasites of Medical and Veterinary Importance.
|
520 |
|
|
|a The volumes included in Antimicrobial Drug Resistance represent the first comprehensive, multidisciplinary reference covering the area of antimicrobial drug resistance in bacteria, fungi, viruses, and parasites from basic science, clinical, and epidemiological perspectives. The first volume, Antimicrobial Drug Resistance, Mechanisms of Drug Resistance, is dedicated to the biological basis of drug resistance and effective avenues for drug development. With the emergence of more drug-resistant strains, the approach to dealing with the drug resistance problem must include the research of different aspects of the mechanisms of bacterial resistance and the dissemination of resistance genes as well as research utilizing new genomic information. These approaches will permit the design of novel strategies to develop new antibiotics and preserve the effectiveness of currently available ones. The second volume, Antimicrobial Drug Resistance, Clinical and Epidemiological Aspects, is devoted to the clinical aspects of drug resistance. Although there is evidence that restricted use of a specific antibiotic can be followed by a decrease in drug resistance to that agent, drug resistance control is not easily achieved. Thus, the infectious disease physician requires input from the clinical microbiologist and infection control specialist to make informed choices for the effective treatment of various strains of drug-resistant pathogens in individual patients. This 2-volume set is an important reference for students in microbiology, infectious disease physicians, medical students, basic scientists, drug development researchers, microbiologists, epidemiologists, and public health practitioners.
|
650 |
|
0 |
|a Diseases.
|
650 |
1 |
4 |
|a Diseases.
|
700 |
1 |
|
|a Mayers, Douglas.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer Nature eBook
|
776 |
0 |
8 |
|i Printed edition:
|z 9781603275934
|
776 |
0 |
8 |
|i Printed edition:
|z 9781603275927
|
776 |
0 |
8 |
|i Printed edition:
|z 9781627038669
|
830 |
|
0 |
|a Infectious Disease
|
856 |
4 |
0 |
|u https://doi.uam.elogim.com/10.1007/978-1-59745-180-2
|z Texto Completo
|
912 |
|
|
|a ZDB-2-SME
|
912 |
|
|
|a ZDB-2-SXM
|
950 |
|
|
|a Medicine (SpringerNature-11650)
|
950 |
|
|
|a Medicine (R0) (SpringerNature-43714)
|